Assertio reports second quarter 2024 financial results

Second quarter total net product sales of $30.7 million rolvedon growth continues, with $15.1 million in net product sales $7.4 million in cash flow from operations, cash and short-term investments increases to $88.4 million lake forest, ill., aug. 07, 2024 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today reported financial results for the second quarter ended june 30, 2024.
ASRT Ratings Summary
ASRT Quant Ranking